Dr. Yuejiao Zhao 赵月皎
Chief Physician
Department of Head and Neck Surgery, Liaoning Cancer Hospital & Institute, Shenyang
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis and treatment of common and complex head and neck diseases, with a focus on thyroid cancer and laryngopharyngeal cancer.
Dr. Zhao holds a doctoral degree in Otolaryngology-Head and Neck Surgery from China Medical University. Recognized as a top talent in Liaoning Province, Dr. Zhao has published over ten papers in core journals and leads multiple provincial research projects.
Professional roles
- Standing Committee Member, Ocular Oncology Professional Committee, China Anti-Cancer Association
- Chair, Head and Neck Oncology Professional Committee, Liaoning Life Science Society
- Vice Chair, Breast Cancer Treatment and Rehabilitation Professional Committee, Liaoning Life Science Society
- Member, Thyroid Study Group, Endocrinology Branch, Liaoning Medical Association
Name order: in Chinese the family name comes first (Zhao Yuejiao). Papers usually list the name as Yuejiao Zhao or Zhao Y.
Selected publications
15 papers on PubMed matched by name and affiliation; 9 as first or senior author since 2016. Most recent first- or senior-author papers:
- Free Radic Biol Med, 2026 (senior author): Bisphenol A drives thyroid carcinogenesis through oxidative stress-lipid metabolic reprogramming via the PTEN/PI3K/AKT axis: Therapeutic reversal by a curcumin-modified quercetin nanomicelle system. PubMed 41985638
- BMC Cancer, 2024 (senior author): LncRNA NEAT1 promotes proliferation, migration, and invasion of laryngeal squamous cell carcinoma cells through miR-411-3p/FZD3-mediated Wnt signaling pathway. PubMed 39068410
- Diagn Pathol, 2023 (senior author): Development of an endoplasmic reticulum stress-related signature with potential implications in prognosis and immunotherapy in head and neck squamous cell carcinoma. PubMed 37087456
- Front Endocrinol (Lausanne), 2022 (senior author): Meta-analysis of TSH suppression therapy and the risk of cardiovascular events after thyroid cancer surgery. PubMed 36619576
- Bioengineered, 2022 (senior author): Overexpression of microRNA-107 suppressed proliferation, migration, invasion, and the PI3K/Akt signaling pathway and induced apoptosis by targeting Nin one binding (NOB1) protein in a hypopharyngeal squamous cell carcinoma cell line (FaDu). PubMed 35294329
- Future Oncol, 2021 (senior author): Overexpressed HGF promotes metastasis of squamous cell carcinoma of the head and neck through the PI3K/Akt and JNK signaling pathways. PubMed 34435890
- Pharmgenomics Pers Med, 2021 (senior author): BRCA2 3'-UTR Polymorphism rs15869 Alters Susceptibility to Papillary Thyroid Carcinoma via Binding hsa-mir-1178-3p. PubMed 33986610
- Braz J Otorhinolaryngol, 2020 (senior author): Which risk factors are associated with stomal recurrence after total laryngectomy for laryngeal cancer? A meta-analysis of the last 30 years. PubMed 32335025
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion